Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- MDWD
- Price
- 17.50
- Stock movement up
- +0.43 (2.52%)
- Company name
- Mediwound Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 224.38M
- Ent value
- 200.27M
- Price/Sales
- 10.72
- Price/Book
- 3.77
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -4.99%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MDWD does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10.72 |
| Price to Book | 3.77 |
| EV to Sales | 9.57 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 12.82M |
| EPS (TTM) | -1.87 |
| FCF per share (TTM) | -1.63 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 20.93M |
| Gross profit (TTM) | 3.88M |
| Operating income (TTM) | -23.55M |
| Net income (TTM) | -20.60M |
| EPS (TTM) | -1.87 |
| EPS (1y forward) | -2.44 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 18.53% |
| Operating margin (TTM) | -112.48% |
| Profit margin (TTM) | -98.43% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 59.09M |
| Net receivables | 6.04M |
| Total current assets | 69.53M |
| Goodwill | 0.00 |
| Intangible assets | 50.00K |
| Property, plant and equipment | 24.38M |
| Total assets | 94.42M |
| Accounts payable | 8.51M |
| Short/Current long term debt | 9.33M |
| Total current liabilities | 26.25M |
| Total liabilities | 34.98M |
| Shareholder's equity | 59.44M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -14.10M |
| Capital expenditures (TTM) | 3.92M |
| Free cash flow (TTM) | -18.02M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -34.66% |
| Return on Assets | -21.82% |
| Return on Invested Capital | -34.06% |
| Cash Return on Invested Capital | -29.79% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 17.05 |
| Daily high | 17.56 |
| Daily low | 16.91 |
| Daily Volume | 106K |
| All-time high | 127.12 |
| 1y analyst estimate | 31.50 |
| Beta | 0.07 |
| EPS (TTM) | -1.87 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MDWD | S&P500 | |
| Current price drop from All-time high | -86.23% | -0.89% |
| Highest price drop | -88.22% | -19.00% |
| Date of highest drop | 4 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -85.72% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
224.38M
Marketcap category
Small-cap
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Employees
111
Website
Investor relations
-
SEC filings
CEO
Sharon Malka
Country
USA
City
Yavne
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page